DK1782070T3 - Tumorassocieret antigenprofiler i cancerdiagnostik og immunterapi - Google Patents

Tumorassocieret antigenprofiler i cancerdiagnostik og immunterapi

Info

Publication number
DK1782070T3
DK1782070T3 DK05766030.0T DK05766030T DK1782070T3 DK 1782070 T3 DK1782070 T3 DK 1782070T3 DK 05766030 T DK05766030 T DK 05766030T DK 1782070 T3 DK1782070 T3 DK 1782070T3
Authority
DK
Denmark
Prior art keywords
immunotherapy
tumor
associated antigen
cancer diagnosis
antigen profiles
Prior art date
Application number
DK05766030.0T
Other languages
English (en)
Inventor
Chih-Sheng Chiang
John J L Simard
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1782070(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mannkind Corp filed Critical Mannkind Corp
Application granted granted Critical
Publication of DK1782070T3 publication Critical patent/DK1782070T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
DK05766030.0T 2004-06-17 2005-06-17 Tumorassocieret antigenprofiler i cancerdiagnostik og immunterapi DK1782070T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58096904P 2004-06-17 2004-06-17
PCT/US2005/021836 WO2006002114A2 (en) 2004-06-17 2005-06-17 Tumor-associated antigen profiles in cancer diagnostics and immunotherapy

Publications (1)

Publication Number Publication Date
DK1782070T3 true DK1782070T3 (da) 2011-01-03

Family

ID=35478743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05766030.0T DK1782070T3 (da) 2004-06-17 2005-06-17 Tumorassocieret antigenprofiler i cancerdiagnostik og immunterapi

Country Status (10)

Country Link
EP (1) EP1782070B1 (da)
JP (1) JP2008503498A (da)
AT (1) ATE480776T1 (da)
AU (1) AU2005258014B2 (da)
CA (1) CA2571070A1 (da)
DE (1) DE602005023488D1 (da)
DK (1) DK1782070T3 (da)
ES (1) ES2351995T3 (da)
MX (1) MXPA06014771A (da)
WO (1) WO2006002114A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101192496B1 (ko) 2003-11-06 2012-10-18 시애틀 지네틱스, 인크. 리간드에 접합될 수 있는 모노메틸발린 화합물
US20060008468A1 (en) * 2004-06-17 2006-01-12 Chih-Sheng Chiang Combinations of tumor-associated antigens in diagnostics for various types of cancers
PL1833506T3 (pl) * 2004-12-29 2016-01-29 Mannkind Corp Zastosowanie kompozycji zawierających różne antygeny związane z nowotworem jako szczepionek przeciwnowotworowych
EP2392672A1 (en) * 2006-06-02 2011-12-07 GlaxoSmithKline Biologicals S.A. Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the CD52 gene
CN101802013B (zh) 2007-07-16 2014-07-02 健泰科生物技术公司 人源化抗cd79b抗体和免疫偶联物及使用方法
PE20090943A1 (es) 2007-07-16 2009-08-05 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados
GB0720118D0 (en) * 2007-10-15 2007-11-28 Achour Adnane Modified mhc class 1 binding peptides
EP2227558A1 (en) * 2007-11-30 2010-09-15 GlaxoSmithKline Biologicals SA Method for classifying cancer patients as responder or non-responder to immunotherapy
EP2657253B1 (en) 2008-01-31 2017-07-19 Genentech, Inc. Anti-CD79b antibodies and immunoconjugates and methods of use
CN101977623A (zh) * 2008-02-20 2011-02-16 亚利桑那生物医学研究委员会 治疗性肽治疗和预防癌症的用途
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
US20120100538A1 (en) 2009-03-24 2012-04-26 Biocept, Inc. Devices and methods of cell capture and analysis
WO2010111388A2 (en) * 2009-03-24 2010-09-30 Biocept, Inc. Devices and methods of cell capture and analysis
US10066004B2 (en) 2010-10-12 2018-09-04 Arizona Cancer Therapeutics, Llc EGFR-based inhibitor peptides for combinatorial inactivation of ERBB1, ERBB2, and ERBB3
EP2627674A4 (en) 2010-10-12 2014-04-30 Arizona Biomedical Res Commission EGFR BASED PEPTIDES
SG191294A1 (en) 2010-12-20 2013-07-31 Genentech Inc Anti-mesothelin antibodies and immunoconjugates
WO2013131050A1 (en) * 2012-03-02 2013-09-06 H. Lee Moffitt Cancer Center & Research Institute, Inc. Materials and methods for differential treatment of cancer
WO2014074785A1 (en) * 2012-11-08 2014-05-15 Ludwig Institute For Cancer Research Ltd. Methods of predicting outcome and treating breast cancer
HUE049175T2 (hu) 2014-09-23 2020-09-28 Hoffmann La Roche Eljárás anti-CD79b immunkonjugátumok alkalmazására
WO2017176946A1 (en) * 2016-04-05 2017-10-12 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for targeted therapy based on single-cell stimulus perturbation response
WO2020150513A1 (en) * 2019-01-17 2020-07-23 Fred Hutchinson Cancer Research Center Methods to enhance the selectivity and effectiveness of cancer treatments

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940670A (en) * 1986-01-24 1990-07-10 Rhodes Buck A Method for compounding and testing patient specific monoclonal antibodies and monoclonal antibody fragments for in vivo use
US6794501B2 (en) 2001-05-04 2004-09-21 Ludwig Institute For Cancer Research Colon cancer antigen panel
DE10225139A1 (de) * 2002-05-29 2004-02-26 Immatics Biotechnologies Gmbh Verfahren zur Identifizierung von immunreaktiven Peptiden

Also Published As

Publication number Publication date
ATE480776T1 (de) 2010-09-15
ES2351995T3 (es) 2011-02-14
WO2006002114A3 (en) 2006-10-05
EP1782070A2 (en) 2007-05-09
JP2008503498A (ja) 2008-02-07
AU2005258014A1 (en) 2006-01-05
CA2571070A1 (en) 2006-01-05
AU2005258014B2 (en) 2012-07-12
WO2006002114A2 (en) 2006-01-05
MXPA06014771A (es) 2007-03-21
DE602005023488D1 (de) 2010-10-21
EP1782070B1 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
DK1782070T3 (da) Tumorassocieret antigenprofiler i cancerdiagnostik og immunterapi
MX2007015946A (es) Combinaciones de antigenos asociados a tumor en diagnosticos para varios tipos de cancer.
CY1123535T1 (el) Υποκαταστατο θεραπευτικο τελικο σημειο για βασιζομενη σε anti-ctla-4 ανοσοθεραπεια ασθενειας
NO20083127L (no) Fremgangsmater og preparater for malretting av polyubiquitin
TNSN05300A1 (en) Treatment with anti-vegf antibodies
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
TW200635608A (en) Aβ antibodies for use in improving cognition
TW200635607A (en) Humanized Aβ antibodies for use in improving cognition
NO20060843L (no) RG1-antistoffer og anvendelser derav
DK1472541T3 (da) Afbildningsmidler og metoder til at afbilde NAALADase og PSMA
MX2008012754A (es) Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica.
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
TNSN08255A1 (en) Anti-mn antibodies and methods of using same
NO20082386L (no) Ligander som har bindingsspesifisitet for EGFR og/eller VEGF og fremgangsmater for anvendelse derav
NO20084356L (no) Anti TAT226-antistoffer og immunokonjugater
DK3530673T3 (da) Humaniserede anti-beta7-antagonister og anvendelser deraf
MXPA04006517A (es) Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores.
EP1742654A4 (en) ANTI-LFL2 ANTIBODIES FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER
MX2008008185A (es) Antigenos de acido des-n-acetil-sialico, anticuerpos para los mismos, y metodos de uso en la terapia de cancer.
BRPI0414513A (pt) kid3 e anticorpos de kid3 que se ligam a ele
NO20090333L (no) Fremgangsmater og preparater rettet mot hepsin
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
WO2004067564A3 (en) Compositions against cancer antigen liv-1 and uses thereof
ATE525401T1 (de) Vom tumorantigen 5t4 abgeleitete mhc-klasse-i- und ii-peptidantigene
CR20220489A (es) Agentes de fijación a tie2 y métodos de uso.